SeaStar Medical Holding Corporation Warrant (ICUCW)
Stock · NASDAQ · Health Care
$0.02as of 10/14/2026
Price chart
About ICUCW
SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUEL…
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Employees
- 18
Fundamentals
- 1-day range
- $0.0159$0.0202
- Market cap
- $79.1K
- P/E (trailing)
- —
- P/E (forward)
- —
- EPS (trailing)
- —
- Dividend yield
- —
- Beta
- 0.83
- Avg. volume
- —
52-week range
$0.0084$0.0452
SeaStar Medical Holding Corporation Warrant Competitors
Chosen by industry and closest market cap.
- ICUCWSeaStar Medical Holding Corporation Warrant$0.02▲ 28.21%Market cap $79.1KP/E —$0.0084$0.0452
- TNONWTenon Medical Inc. Warrant$0.0054▼ 8.47%Market cap $85.3KP/E —$0.0038$0.043
- WOKWORK Medical Technology Group LTD Class A Ordinary Shares$1.09▼ 18.66%Market cap $35.7KP/E —$1.25$83,600
- PFSAProfusa Inc. Common Stock$0.931▼ 12.99%Market cap $686.5KP/E —$1.25$3,000
- VTAKCatheter Precision Inc. Common Stock$0.84▼ 14.29%Market cap $977.1KP/E —$0.82$30.6
- BJDXBluejay Diagnostics Inc. Common Stock$0.745▼ 4.36%Market cap $1.19MP/E —$0.755$16.68
- BEATWHeartbeam Inc. Warrant$0.0031▼ 65.56%Market cap $1.19MP/E —$0.005$0.5601
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| ICUCW SeaStar Medical Holding Corporation Warrant | $79.1K | — | $0.02 | ▲ 28.21% | $0.0084$0.0452 |
| TNONW Tenon Medical Inc. Warrant | $85.3K | — | $0.0054 | ▼ 8.47% | $0.0038$0.043 |
| WOK WORK Medical Technology Group LTD Class A Ordinary Shares | $35.7K | — | $1.09 | ▼ 18.66% | $1.25$83,600 |
| PFSA Profusa Inc. Common Stock | $686.5K | — | $0.931 | ▼ 12.99% | $1.25$3,000 |
| VTAK Catheter Precision Inc. Common Stock | $977.1K | — | $0.84 | ▼ 14.29% | $0.82$30.6 |
| BJDX Bluejay Diagnostics Inc. Common Stock | $1.19M | — | $0.745 | ▼ 4.36% | $0.755$16.68 |
| BEATW Heartbeam Inc. Warrant | $1.19M | — | $0.0031 | ▼ 65.56% | $0.005$0.5601 |
P/E shows — for peers not currently carrying a live signal of their own.
Institutional Ownership
March 31, 2026
- Total shares held
- 989.8K
- Total value held
- $933.3K
- Institutional holders
- 11
Top holders this quarter
- Unknown245.2K
- Unknown218.1K
- Unknown211.4K
- Unknown125.0K
- Unknown46.5K
- Unknown40.0K
- Unknown35.7K
- Unknown32.5K
- Unknown22.5K
- Unknown12.3K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 3, 2026
SeaStar Medical Secures New ICD-10 Codes and ASN Presentation
SeaStar Medical Holding Corporation announced that new ICD-10-PCS codes are now available for its SCD therapy used to treat acute kidney injury. The company also confirmed a late-breaking presentation at ASN Kidney Week 2026 and a speaking slot at the PPETS 2026 symposium. These developments highlight ongoing clinical and regulatory milestones for the company's medical devices.
SeaStar Medical Secures New ICD-10 Codes and ASN Presentation. SeaStar Medical Holding Corporation announced that new ICD-10-PCS codes are now available for its SCD therapy used to treat acute kidney injury. The company also confirmed a late-breaking presentation at ASN Kidney Week 2026 and a speaking slot at the PPETS 2026 symposium. These developments highlight ongoing clinical and regulatory milestones for the company's medical devices.